# Mesenchymal Stromal Cells (MSC´s) in Renal Lupus

> **NCT03917797** · PHASE2 · UNKNOWN · sponsor: **Universidad de los Andes, Chile** · enrollment: 39 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic
- Lupus Glomerulonephritis

## Interventions

- **BIOLOGICAL:** MSC treatment
- **DRUG:** Standard of Care
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03917797
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-02
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03917797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03917797, "Mesenchymal Stromal Cells (MSC´s) in Renal Lupus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03917797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*